Sign In

Login

Password

Forgot Password ? Sign Up

دينوسوماب (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "دينوسوماب" in Arabic language version.

refsWebsite
Global rank Arabic rank
10web.archive.org
1st place
1st place
10nih.gov
4th place
6th place
6doi.org
2nd place
5th place
1wikidata.org
43rd place
2nd place
1landesbioscience.com
low place
low place
1amgen.com
low place
low place
1biosciencetechnology.com
low place
low place
1genengnews.com
low place
low place
1medpagetoday.com
9,274th place
low place
1onclive.com
low place
low place
1europa.eu
68th place
91st place
1urotoday.com
low place
low place
1nytimes.com
7th place
23rd place
1cancer.gov
1,684th place
1,025th place

amgen.com

biosciencetechnology.com

cancer.gov

doi.org

  • Drug Indications Extracted from FAERS، DOI:10.5281/ZENODO.1435999، QID:Q56863002
  • Pageau، Steven C. (2009). "Denosumab". MAbs. ج. 1 ع. 3: 210–215. DOI:10.4161/mabs.1.3.8592. PMC:2726593. PMID:20065634. مؤرشف من الأصل في 2012-03-08.
  • McClung، Michael R.؛ Lewiecki، E. Michael؛ Cohen، Stanley B.؛ Bolognese، Michael A.؛ Woodson، Grattan C.؛ Moffett، Alfred H.؛ Peacock، Munro؛ Miller، Paul D.؛ Lederman، Samuel N. (2006). "Denosumab in Postmenopausal Women with Low Bone Mineral Density". New England Journal of Medicine. ج. 354 ع. 8: 821–31. DOI:10.1056/NEJMoa044459. PMID:16495394.
  • Ellis، G. K.؛ Bone، H. G.؛ Chlebowski، R.؛ Paul، D.؛ Spadafora، S.؛ Smith، J.؛ Fan، M.؛ Jun، S. (2008). "Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer". Journal of Clinical Oncology. ج. 26 ع. 30: 4875–82. DOI:10.1200/JCO.2008.16.3832. PMID:18725648.
  • Cummings، Steven R.؛ Martin، Javier San؛ McClung، Michael R.؛ Siris، Ethel S.؛ Eastell، Richard؛ Reid، Ian R.؛ Delmas، Pierre؛ Zoog، Holly B.؛ وآخرون (2009). "Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis". New England Journal of Medicine. ج. 361 ع. 8: 756–65. DOI:10.1056/NEJMoa0809493. PMID:19671655.
  • Khosla، S (2009). "Increasing options for the treatment of osteoporosis". New England Journal of Medicine. ج. 361 ع. 8: 818–820. DOI:10.1056/NEJMe0905480. PMID:19671654.

europa.eu

ema.europa.eu

genengnews.com

landesbioscience.com

medpagetoday.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Pageau، Steven C. (2009). "Denosumab". MAbs. ج. 1 ع. 3: 210–215. DOI:10.4161/mabs.1.3.8592. PMC:2726593. PMID:20065634. مؤرشف من الأصل في 2012-03-08.
  • McClung، Michael R.؛ Lewiecki، E. Michael؛ Cohen، Stanley B.؛ Bolognese، Michael A.؛ Woodson، Grattan C.؛ Moffett، Alfred H.؛ Peacock، Munro؛ Miller، Paul D.؛ Lederman، Samuel N. (2006). "Denosumab in Postmenopausal Women with Low Bone Mineral Density". New England Journal of Medicine. ج. 354 ع. 8: 821–31. DOI:10.1056/NEJMoa044459. PMID:16495394.
  • Ellis، G. K.؛ Bone، H. G.؛ Chlebowski، R.؛ Paul، D.؛ Spadafora، S.؛ Smith، J.؛ Fan، M.؛ Jun، S. (2008). "Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer". Journal of Clinical Oncology. ج. 26 ع. 30: 4875–82. DOI:10.1200/JCO.2008.16.3832. PMID:18725648.
  • Lipton، A؛ Fizazi، K؛ Stopeck، AT؛ Henry، DH؛ Brown، JE؛ Yardley، DA؛ Richardson، GE؛ Siena، S؛ Maroto، P؛ Clemens، M؛ Bilynskyy، B؛ Charu، V؛ Beuzeboc، P؛ Rader، M؛ Viniegra، M؛ Saad، F؛ Ke، C؛ Braun، A؛ Jun، S (نوفمبر 2012). "Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials". European journal of cancer (Oxford, England : 1990). ج. 48 ع. 16: 3082–92. PMID:22975218.
  • Zhou، Z؛ Chen، C؛ Zhang، J؛ Ji، X؛ Liu، L؛ Zhang، G؛ Cao، X؛ Wang، P (2014). "Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis". International journal of clinical and experimental pathology. ج. 7 ع. 5: 2113–22. PMID:24966919.
  • Josse، R؛ Khan، A؛ Ngui، D؛ Shapiro، M (مارس 2013). "Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis". Current medical research and opinion. ج. 29 ع. 3: 205–16. PMID:23297819.
  • Cummings، Steven R.؛ Martin، Javier San؛ McClung، Michael R.؛ Siris، Ethel S.؛ Eastell، Richard؛ Reid، Ian R.؛ Delmas، Pierre؛ Zoog، Holly B.؛ وآخرون (2009). "Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis". New England Journal of Medicine. ج. 361 ع. 8: 756–65. DOI:10.1056/NEJMoa0809493. PMID:19671655.
  • Khosla، S (2009). "Increasing options for the treatment of osteoporosis". New England Journal of Medicine. ج. 361 ع. 8: 818–820. DOI:10.1056/NEJMe0905480. PMID:19671654.

ncbi.nlm.nih.gov

  • Pageau، Steven C. (2009). "Denosumab". MAbs. ج. 1 ع. 3: 210–215. DOI:10.4161/mabs.1.3.8592. PMC:2726593. PMID:20065634. مؤرشف من الأصل في 2012-03-08.
  • EntrezGene 8600 TNFSF11]]tumor necrosis factor (ligand) superfamily, member 11; Homo sapiens
    «also known as RANKL .. This protein was shown to be a dentritic cell survival factor and is involved in the regulation of T cell-dependent immune response.»

nytimes.com

onclive.com

urotoday.com

web.archive.org

wikidata.org

  • Drug Indications Extracted from FAERS، DOI:10.5281/ZENODO.1435999، QID:Q56863002